Bio-Techne Corp. (TECH)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 12:05 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow TECH in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on TECH and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
TECH at a glance
Key statistics
$11.38B
Market capitalization
- Previous close
- $72.58
- Open
- $72.53
- Day range
- $72.52 – $72.63
- Volume
- 1.86M
- Average volume (30 sessions)
- 3.05M
- Shares outstanding
- 156.82M
- Price / earnings
- 62.6
- Earnings per share
- $1.16
- Price / book
- 5.4
- Price / sales
- 9.4
- Dividend yield
- 0.44%
- Beta (1 year, vs SPY)
- 0.77
Where the price sits in its year
52-week range
100% of the range
- Below the 52-week high
- -0.1%
- Above the 52-week low
- +68.1%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $72.50+0.1%
- 50-day average
- $72.39+0.3%
- 200-day average
- $62.88+15.4%
Between the conventional 30 and 70 bands.
+0.1%
1 week
+0.2%
1 month
+1.1%
3 months
+23.4%
Year to date
+17.3%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with TECH
TECH on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on TECH.
See the plans →
Every planScreen names like TECH
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on TECH
Put TECH on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on TECH
See whether there is an open premium alert on TECH, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
TECH headlines
- Bio-Techne Declares Dividend
Benzinga · Feb 4, 2026
- Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Benzinga · Sep 15, 2025
- BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
Benzinga · May 7, 2025
- CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs
GlobeNewswire Inc. · Oct 21, 2024
- Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Benzinga · May 22, 2024
- Navigating 4 Analyst Ratings For Bio-Techne
Benzinga · Apr 18, 2024
SEC Form 4, most recent first
Insider filings
HIGGINS JOHN L
+15.9K
Director · Option exercise
· Sep 28, 2026
HIGGINS JOHN L
−5.6K
Director · Shares withheld for tax
$403.30K · Sep 28, 2026
HIGGINS JOHN L
−15.9K
Director · Option exercise
· Sep 28, 2026
BAUMGARTNER ROBERT V
−5.6K
Director · Shares withheld for tax
$403.31K · Sep 22, 2026
BAUMGARTNER ROBERT V
−15.9K
Director · Option exercise
· Sep 22, 2026
BAUMGARTNER ROBERT V
+15.9K
Director · Option exercise
· Sep 22, 2026
About Bio-Techne Corp.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- Minneapolis, MN
- Employees
- 3,000
- Listed since
- May 8, 1989
- Website
- bio-techne.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.